$572 Million Judgment in Landmark Oklahoma Opioid Lawsuit

Share this post

The judge in the Oklahoma opioid lawsuit ruled that opioid marketing by Johnson & Johnson and its subsidiary Janssen "created a nuisance" that compromised the health of thousands in the state.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply